Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

A downtrend has been apparent in Fresenius (FMS) lately. While the stock has lost 9.1% over the past four weeks, it could ...

Investors in Fresenius Medical Care AG FMS need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest ...

Azenta will support the collaboration by delivering genomic sequencing through GENEWIZ and managing long-term sample storage within its global biorepository network. With decades of experience in ...

On July 14, 2025 Fresenius filed two IPR petitions challenging Regeneron’s patents related to aflibercept. Regeneron has not asserted that ...

Willmar has been home to a dialysis clinic since the 1960s when the city-owned Rice Memorial Hospital established a program. The clinic is now operated by Fresenius Kidney Care in a new location.

Fresenius’s sprawling business is getting tighter. On Tuesday evening the $17 billion German medical technology company said it will relinquish control of its listed dialysis firm, Fresenius ...

Shares in the world's largest kidney dialysis provider Fresenius Medical Care (FMC) plunged more than 12% to a 12-year low on Thursday after it cut its earnings outlook as costs surge and a U.S ...

Fresenius SE FRE -0.87% said it raised around 1.1 billion euros ($1.15 billion) after selling part of its Fresenius Medical Care FME -1.40% shares and placing bonds. The German healthcare company ...

Fresenius Medical Care could end up benefiting from blockbuster obesity drugs, according to its chief executive, contrary to concerns that such treatments could be negative for the dialysis ...